WATERTOWN, Mass., Jan. 03, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic
products, today announced that Ocumension Therapeutics, a China-based ophthalmic pharmaceutical company traded on the Stock Exchange of Hong Kong (1477.HK), has made a $15.7 million equity
investment in
products, today announced that Ocumension Therapeutics, a China-based ophthalmic pharmaceutical company traded on the Stock Exchange of Hong Kong (1477.HK), has made a $15.7 million equity
investment in
Bitcoin 
Ethereum 
Tether 
BNB 
USD Coin 
XRP 
Cardano 
Dogecoin 
Lido Staked Ether 
Polygon
Neueste Kommentare